Workflow
赛科希德2025年中报简析:净利润同比下降23.47%,三费占比上升明显

Core Viewpoint - The financial performance of Saikohide (688338) for the first half of 2025 shows a significant decline in revenue and net profit compared to the previous year, indicating challenges in the market and increased operational costs [1] Financial Performance Summary - Total revenue for the first half of 2025 was 139 million yuan, a decrease of 12.62% year-on-year [1] - Net profit attributable to shareholders was 47.99 million yuan, down 23.47% year-on-year [1] - Gross margin was 62.13%, a decrease of 1.37 percentage points year-on-year, while net margin was 34.51%, down 12.47 percentage points [1] - Total expenses (selling, administrative, and financial) accounted for 15.42% of total revenue, an increase of 47.39% year-on-year [1] - Earnings per share decreased to 0.46 yuan, down 22.03% year-on-year [1] Cash Flow and Asset Management - Cash flow from operating activities decreased by 28.55%, attributed to reduced sales revenue and slower collection of receivables [5] - The company increased its investment in structured deposits, leading to a 29.33% decrease in cash and cash equivalents [3] - The company reported a 150.08% increase in trading financial assets due to the same investment strategy [3] Revenue and Cost Analysis - Revenue decline of 12.62% was influenced by stricter management of inspection projects by medical institutions and reduced sales of reagents and consumables [5] - Operating costs also decreased by 10.57%, reflecting the overall drop in revenue [5] Debt and Liabilities - The company’s interest-bearing liabilities decreased by 14.87% [1] - Employee compensation liabilities decreased by 43.35% due to the payment of annual bonuses [4] Investment and Return Metrics - The company's return on invested capital (ROIC) was 5.49%, indicating average capital returns [8] - Historical data shows a median ROIC of 6.48% since the company’s listing, with the lowest recorded ROIC at 4.98% in 2021 [8] Overall Financial Health - The company maintains a healthy cash asset position, indicating good liquidity despite the decline in revenue and profit [9]